Supplementary Table 8. Associations of sdLDL-C Levels and TG Levels with Primary Cardiovascular Events During Follow-up.
| Variables, n (%) | Group 1 | Group 2 | Group 3 | Group 4 | P value |
|---|---|---|---|---|---|
| TG ＜150 mg/dL | TG ≥ 150 mg/dL | ||||
|
sdLDL-C ＜40.0 mg/dL (n= 112) |
sdLDL-C ≥ 40.0 mg/dL (n= 15) |
sdLDL-C ＜40.0 mg/dL (n= 32) |
sdLDL-C ≥ 40.0 mg/dL (n= 39) |
||
| Primary cardiovascular events | 10 (8.9) | 5 (33.3) | 6 (18.8) | 13 (33.3) | 0.002 |
| Death from cardiovascular disease | 2 (1.8) | 1 (6.7) | 0 (0) | 0 (0) | 0.28 |
| Non-fatal stroke | 0 (0) | 1 (6.7) | 0 (0) | 2 (5.1) | 0.04 |
| Angina pectoris | 8 (7.1) | 3 (20.0) | 4 (12.5) | 7 (18.0) | 0.18 |
| Non-fatal acute coronary syndrome | 0 (0) | 0 (0) | 2 (6.3) | 4 (10.3) | 0.01 |
TG indicates triglycerides; sdLDL-C, small dense low-density lipoprotein cholesterol.
Primary cardiovascular events include death from cardiovascular disease, non-fatal acute coronary syndrome, non-fatal stroke, and angina pectoris. Group 1 indicates TG of ＜150 mg/dL and sdLDL-C of ＜40.0 mg/dL; group 2, TG of ＜150 mg/dL and sdLDL-C of ≥ 40.0 mg/dL; group 3, TG of ≥ 150 mg/dL and sdLDL-C of ＜40.0 mg/dL; group 4, TG of ≥ 150 mg/dL and sdLDL-C of ≥ 40.0 mg/dL.